PMH10 Selective Serotonin Reuptake Inhibitor Utilization Patterns: Consistency Across Research Designs

Selective Serotonin Reuptake Inhibitor Citalopram

Background and Purpose The aim of the study was to investigate the efficacy and safety of the selective serotonin reuptake inhibitor citalopram in treating poststroke depression, since available treatments are usually poorly tolerated. Methods A 6-week double-blind, placebo-controlled trial was undertaken. Diagnosis and outcome were determined using the Hamilton Depression Scale, and unwanted e...

Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions.

Serotonin syndrome is a rare but potentially fatal adverse drug reaction associated with increased serotonergic activity in the central nervous system. It is characterized by a triad of symptoms, which include altered mental status, neuromuscular hyperactivity, and autonomic instability or hyperactivity. Due to the potential of rapid onset, it is important for clinicians to recognize the signs ...

Selective Serotonin Reuptake Inhibitors

It has long been postulated that a deficiency in CNS serotonergic activity is the cause of, or a predisposing factor for, depression. [1] However, the evidence for this association is largely circumstantial and it certainly does not represent an adequate and full model for depression, probably due to there being multiple aetiological factors. [2] Some pharmacological trial data also cast doubt ...

Selective serotonin reuptake inhibitors.

Desvenlafaxine (pristiq): a Selective Serotonin and Norepinephrine Reuptake Inhibitor

Volume 23, Issue 9 June 2008 1 Major depressive disorder (MDD) is characterized as a disabling psychiatric disorder, presenting with a loss of pleasure and interest in activities that normally bring satisfaction and enjoyment. MDD is a common disorder, roughly occurring at least once in the lifetime of 16.2% of US adults (32.6-35.1 million people), and at least once in the past year of 6.6% of ...